Jump to Navigation

Secondary menu

  • Contact
  • People
  • Glossary
  • Useful Links
  • Site map
European Vaccine Initiative Todays Catalyst for tomorrows Vaccines
  • Home
  • Portfolio
    • Vaccine development
    • Coordination
    • Services
    • Harmonisation
    • Capacity strengthening
      • AMA1-DiCo sponsored students
      • EMVDA PhD sponsorships
      • MVVC sponsored students
    • Project index
    • Projects no longer active
      • AMA1
      • GLURP (GMZ1)
      • GMZ2
      • MSP3
      • Polyprotein FP9 PP and MVA PP
      • TBV
      • Var2-CSA DBL3-X
      • Var2CSA
  • Calls & Grants
    • Application procedure
    • Apply now
    • Recent awards
    • Directives, policies and guidelines
      • Good Manufacturing Practice
      • Good Clinical Practice
      • Regulations on medicinal products
      • Environmental policy
  • International Relations
    • Contractual partners
    • International membership
    • Memoranda of Understanding and Intent
  • Vaccines & Diseases
    • Vaccines
      • Vaccination
      • Delivery of vaccines
      • Stages of development
    • Diseases of poverty
      • Chagas Disease
      • Dengue
      • HIV/AIDS
      • Leishmaniasis
      • Malaria
      • Tuberculosis
  • About us
    • Mission and Aims
    • Strategy
    • The Donors
    • Governance
      • Board of Stakeholders
      • Board
      • Scientific Advisory Committee
      • Secretariat
    • Our achievements
    • Annual Reports
    • EVI News Letters
    • Publications and articles
      • 2013
      • 2012
      • 2011
      • 2009 - 2010
      • 2008
      • 2007
      • 2004 - 2006
    • Contact us
    • Vacancies
  • News & Events
    • News
    • Events
      • Events attended by EVI
      • Events of general interest
      • EVI Rendez-Vous Events
        • EVI Rendez-Vous, 6 December 2012
        • EVI Rendez-Vous 14 November 2011
      • EVI 15th Anniversary Symposium
      • Vaccinology courses
    • Meeting reports
About us › EVI News Letters

EVI News Letters

2011

News Letter no. 1

News Letter no. 2

News Letter no. 3

The new EVI call targetting INNOVATION is now closed. EVI extends thanks to all applicants.
  • Disclaimer
  • Privacy
| © European Vaccine Initiative - UniversitätsKlinikum Heidelberg 2013 | Designed by art/Grafik. Powered by Manta Ray Media Ltd, London